This is the number of shares you have owned in Regeneron Pharmaceuticals over the past 15 years – Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals regn Over the past 15 years, the age has exceeded 12.37% annually, with an average annual rate of return of 24.38%. Currently, Regeneron Pharmaceuticals has a market capitalization of US$74.02 billion.

Buy a $100 Regn: If an investor bought $100 in REGN stock 15 years ago, it would be worth it $2,562.19 Today, at the time of writing, REGN is priced at $673.60.

Regeneron Pharmaceuticals’ performance over the past 15 years

Finally – What does all this mean? The main insights from this article are to be aware of how much difference your cash growth can make over a period of time.

This article was generated by Benzinga’s automatic content engine and reviewed by editors.